Ignite Creation Date:
2024-05-06 @ 10:23 AM
Last Modification Date:
2024-10-26 @ 12:29 PM
Study NCT ID:
NCT03248531
Status:
COMPLETED
Last Update Posted:
2022-04-11
First Post:
2017-08-02
Brief Title:
A Study to Test the Efficacy Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-22
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-02-21
Completion Date Type:
ACTUAL
First Submit Date:
2017-08-02
First Submit QC Date:
August 11 2017
Study First Post Date:
2017-08-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-02-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2019-11-22
Disp First Submit QC Date:
January 13 2022
Disp First Post Date:
2022-02-09
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-03-14
Last Update Post Date:
2022-04-11
Last Update Post Date Type:
ACTUAL